Skip to main content

REVIEW article

Front. Pharmacol.
Sec. Ethnopharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1494277
This article is part of the Research Topic Drug Discovery Derived from Herbal Medicine/Polypeptide for Neurological Diseases View all 11 articles

The Protective Effects of Gastrodin on Neurological Disorders: An Update and Future Perspectives

Provisionally accepted
Zhouying Shi Zhouying Shi 1*Yali Zhang Yali Zhang 1*Yuhua Xiao Yuhua Xiao 1*Zhoujing Shi Zhoujing Shi 2Xiaotong Wei Xiaotong Wei 1Bin Wang Bin Wang 1*Yue Yuan Yue Yuan 1*Ping Li Ping Li 1*
  • 1 Changchun University of Chinese Medicine, Changchun, China
  • 2 School of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China

The final, formatted version of the article will be published soon.

    Neurological disorders are characterized by high mortality and disability rates. Furthermore, the burden associated with disability and mortality resulting from neurological disorders has been increasing at an alarming rate. Botanical drugs and their bioactive components have emerged as a prominent area of research, offering a promising avenue for developing novel alternatives for treating neurological diseases. Gastrodin is the principal active component derived from the traditional Chinese medicinal plant Gastrodia elata Blume (GEB). Existing literature reveals that gastrodin exerts various pharmacological protective actions against neurological disorders. This review aimed to collate novel literature on gastrodin for treating neurological disorders from Web of Science, PubMed, Embase and CNKI. The pharmacokinetics of gastrodin, its therapeutic role in neurological disorders, the main mechanisms of action and clinical application were addressed. Furthermore, a detailed overview of gastrodin drug delivery systems and physical enhancement methods was presented, offering invaluable insights into potential research and the extensive applications of gastrodin.

    Keywords: Gastrodin, neurological disorders, molecular mechanism, Pharmacological effects, pharmacokinetics, drug delivery system

    Received: 10 Sep 2024; Accepted: 14 Nov 2024.

    Copyright: © 2024 Shi, Zhang, Xiao, Shi, Wei, Wang, Yuan and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Zhouying Shi, Changchun University of Chinese Medicine, Changchun, China
    Yali Zhang, Changchun University of Chinese Medicine, Changchun, China
    Yuhua Xiao, Changchun University of Chinese Medicine, Changchun, China
    Bin Wang, Changchun University of Chinese Medicine, Changchun, China
    Yue Yuan, Changchun University of Chinese Medicine, Changchun, China
    Ping Li, Changchun University of Chinese Medicine, Changchun, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.